Option Focus | Moderna's $5.39 Million Bear Put Spread and $1.01 Million Bear Call Spread Reveal Institutional Bias Toward Further Downside

Option Witch11-14

Moderna ended the session at $223.37, a decline of 3.45%.

The options tape showed heavy institutional positioning, led by a $5.39 million bear put spread and a $1.01 million bear call spread. Both structures carried bearish directional conviction, pairing a net-debit long put spread with a net-credit call spread. The flow leaned entirely toward downside exposure, suggesting large traders are actively positioning for further weakness in Moderna rather than a rebound.

>>Don’t Let Fees Quietly Eat Into Your Returns — Get up to SGD 200 in Options Rewards!

Options Indicators

Moderna currently has an implied volatility of 84.15%, while its IV percentile stands at 63.35%, which places current volatility expectations in a broadly neutral historical range rather than an extreme one. Even so, with options carrying a high absolute IV and an IV/HV ratio of 0.79, the market’s implied pricing appears somewhat restrained relative to recent realized volatility, suggesting options are not being priced at an especially rich premium despite the elevated nominal volatility level.

The Call/Put volume ratio is 1.14.

Large Trades

A bearish put spread with a $5.39 million net debit was the largest featured trade, built by buying 1,500 March 19, 2027 $220.00 puts and selling 1,500 March 19, 2027 $120.00 puts. With the stock reference price at $223.37, both put strikes were out of the money at execution. As a bear put spread, this is a defined-risk bearish structure in which the trader paid premium upfront to position for downside into expiration while partially offsetting the cost by selling the lower-strike put. The net debit indicates this was a directional bearish bet rather than premium collection, expressing expectations for weakness in MRNA but with profits capped below the short $120.00 put strike.

A bearish call spread with a $1.01 million net credit was the second major trade, consisting of the sale of 2,499 November 20, 2026 $237.50 calls and the purchase of 2,499 November 20, 2026 $255.00 calls. Relative to the $223.37 stock reference, both call strikes were out of the money. This bear call spread is a credit spread designed to collect premium while leaning bearish to neutral, as the trader benefits if MRNA stays below the $237.50 short-call strike through expiration. The purchased $255.00 call caps upside risk, making this a hedged premium-selling stance that still reflects a negative directional view on the shares.

Overall, the large-trade flow points clearly bearish on MRNA. The positioning was entirely one-sided in favor of downside exposure, combining a sizable net-debit bear put spread that targets a meaningful drop with a net-credit bear call spread that monetizes expectations for capped upside and price stagnation below resistance. Together, these trades suggest institutional traders are not just cautious but actively positioning for weakness, with sentiment skewed toward further downside rather than recovery.

Strategy Reference

For a low-assignment-probability premium-selling approach, consider shorting an out-of-the-money call above the $255.00 resistance area, or structure a bear call spread such as selling the $237.50 call and buying the $255.00 call to define risk while aligning with the bearish flow.

Click to claim your commission-free cards before trading!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment